ENHERTU vs EXEMESTANE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. ENHERTU and EXEMESTANE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ENHERTU	EXEMESTANE
Rating	New	72/100
Pharmacy pays	—	~$18.36 /30
Type	RX	RX
Active ingredient	FAM-TRASTUZUMAB DERUXTECAN-NXKI	EXEMESTANE
Manufacturer	Daiichi Sankyo Inc	Rising
Dosage forms	Injectable	Tablet
Drug class	—	Aromatase Inhibitor
Boxed warning	Boxed warning	None
Treats	Breast Neoplasms, Gastrointestinal Neoplasms	Breast Neoplasms

enhertu exemestane

Rating

New

72/100

Pharmacy pays

—

~$18.36 /30

Type

Active ingredient

FAM-TRASTUZUMAB DERUXTECAN-NXKI

EXEMESTANE

Manufacturer

Daiichi Sankyo Inc

Rising

Dosage forms

Injectable

Tablet

Drug class

—

Aromatase Inhibitor

Boxed warning

None

Treats

Breast Neoplasms, Gastrointestinal Neoplasms

Breast Neoplasms

Frequently asked questions

What is the difference between Enhertu and Exemestane?

Enhertu contains Fam-Trastuzumab Deruxtecan-Nxki, while Exemestane contains Exemestane — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.